Question 41

Desvenlafaxine has a boxed warning for increased risk of suicidal thoughts and behaviors.

Desvenlafaxine is the medication that carries a boxed warning due to its association with an increased risk of suicidal thoughts and behaviors, particularly in children, adolescents, and young adults.

A) Desmopressin

Desmopressin is not associated with an increased risk of suicidal thoughts or behaviors, and therefore does not carry a boxed warning for this concern. It is primarily used to treat conditions such as diabetes insipidus and bedwetting.

B) Desvenlafaxine

Desvenlafaxine is an antidepressant that belongs to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs). It has a boxed warning indicating that it may increase the risk of suicidal thoughts and behaviors, especially in younger populations, making this option correct.

C) Dexlansoprazole

Dexlansoprazole is a proton pump inhibitor used to treat gastroesophageal reflux disease (GERD). It does not have any warnings related to suicidal thoughts or behaviors, thus making it an incorrect choice.

D) Desloratadine

Desloratadine is an antihistamine used to treat allergies and does not have a boxed warning concerning suicidal thoughts or behaviors. This makes it an incorrect option as well.

Conclusion

Desvenlafaxine is definitively the correct answer as it specifically carries a boxed warning about the potential for increased suicidal thoughts and behaviors. In contrast, the other options do not have such warnings and are used for entirely different medical conditions, demonstrating the importance of awareness regarding the side effects of medications.